Overview Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903 Status: Completed Trial end date: 2020-09-07 Target enrollment: Participant gender: Summary A Randomized, Open-label, Oral in healthy male volunteers Phase: Phase 1 Details Lead Sponsor: Daewon Pharmaceutical Co., Ltd.